Quick Takeaways
- RTW INVESTMENTS, LP filed SCHEDULE 13G/A for TAYSHA GENE THERAPIES, INC. Common Stock, par value $0.00001 per share (TSHA).
- Disclosed ownership: 8.3%.
- Date of event: 31 Dec 2025.
RTW INVESTMENTS, LP - 31 Dec 2025 SCHEDULE 13G/A Report for TAYSHA GENE THERAPIES, INC. Common Stock, par value $0.00001 per share (TSHA)
- Filing Manager
- RTW INVESTMENTS, LP
- Reporting Manager
- RTW Investments, LP
- Symbol
- TSHA
- Shares outstanding
- 282,013,651 shares
- Disclosed Ownership
- 23,407,133 shares
- Ownership
- 8.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 08:49:15 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RTW INVESTMENTS, LP disclosed 8.3% ownership in TAYSHA GENE THERAPIES, INC. Common Stock, par value $0.00001 per share (TSHA) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 17 Feb 2026, 08:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RTW Investments, LP | 8.3% | 23,407,133 | 0 | 23,407,133 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D., Managing Partner | |
| Roderick Wong | 8.3% | 23,407,133 | 0 | 23,407,133 | s/ Roderick Wong, M.D. | Roderick Wong, M.D. |